Disclosure Statement

GMD is a consultant for MedTronic ENT. RTK has received grant-research support from Genzyme, Bayer-Onyx, Eisai, and Veracyte; is a consultant for Genzyme, Bayer-Onyx, Abbott, and Veracyte; and is on the Speakers Bureau for Genzyme and Abbott. He has received no honoraria for commercial speaking since November 2006 and all commercial consulting since that time has been approved by the ATA Board of Directors, the ATA Ethics Committee, and has been without financial compensation. SJM has received grant-research support from Veracyte and has been a CME speaker for Genzyme. GWR has been a consultant for Genzyme. DLS has received grant-research support from Veracyte, Wyeth, Astra-Zeneca, and Gyrus. RMT is a consultant for Genzyme, Abbott, and Eli Lily, and has received honoraria from Genzyme and Abbott. SEC, DSC, Q-YD, BCS Jr., DJT, GBT, RPT, and RU report that no competing financial interests exist.